Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
Study for Reference Intervals and Optimal Cut-offs for Salivary Cortisol
1 other identifier
observational
220
1 country
1
Brief Summary
The goal of this observational study is to establish the normal reference intervals of salivary cortisol and optimal cut-offs for Cushing's sydrome and adrenal insufficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 11, 2025
August 1, 2025
1.8 years
August 27, 2025
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Reference intervals of salivary cortisol
Salivary cortisol levels were evaluated by immunomagnetic-bead-based LC-MS assay and fluorescence immunoassay system to establish its reference intervals according to the 2.5th and 97.5th percentiles.
8:00, 16:00 and 23:00 on the day of sample collection
Optimal cut-off and diagnostic accuracy of salivary cortisol in Cushing's syndrome
The diagnostic cut-off for each analysis method was defined as either the calculated upper reference interval (97.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for Cushing's syndrome was calculated using samples from all available healthy controls and cases.
23:00 on the day of sample collection
Optimal cut-off and diagnostic accuracy of salivary cortisol in adrenal insufficiency
The diagnostic cut-off for each analysis method was defined as either the calculated lower reference intervals (2.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for adrenal insufficiency was calculated using samples from all available healthy controls and cases.
8:00 on the day of sample collection
Comparison of diagnostic accuracy of salivary cortisol in Cushing's syndrome and adrenal insufficiency
The diagnostic accuracies of the fluorescence immunoassay system and the immunomagnetic-bead-based LC-MS assay were compared by analyzing their areas under the receiver operating characteristic (ROC) curves using DeLong's test for paired statistics.
8:00 or 23:00 on the day of sample collection
Secondary Outcomes (4)
Agreement in assessment of salivary cortisol
8:00, 16:00 and 23:00 on the day of sample collection
Between-groups differences in salivary cortisol of healthy volunteers with different age ranges
8:00, 16:00 and 23:00 on the day of sample collection
Between-groups differences in salivary cortisol of healthy volunteers with different sex
8:00, 16:00 and 23:00 on the day of sample collection
Between-groups differences in salivary cortisol of healthy volunteers with different body mass index ranges
8:00, 16:00 and 23:00 on the day of sample collection
Study Arms (3)
Heathy Volunteers
120 Healthy Volunteers for the establishment of reference intervals of salivary cortisol
Cushing's sydrome
50 cases diagnosed with Cushing's sydrome
Adrenal insufficiency
50 cases diagnosed with adrenal insufficiency
Eligibility Criteria
The participants are enrolled from Shanghai Sixth People's Hospital, Shanghai.
You may qualify if:
- Age ≥ 18 and ≤ 60 years old;
- Body mass index (BMI) ≥ 18.5 and ≤ 24.9 kg\*m\^-2;
- No previous history of chronic diseases such as hyperglycemia, hypertension, dyslipidemia, coronary heart disease and stroke;
- Normal glucose regulation, defined as: fasting blood-glucose \< 5.6 mmol/L, 2-hour blood-glucose after glucose load \< 7.8 mmol/L, and glycated hemoglobin (HbA1c) \< 5.7%.
You may not qualify if:
- Liver or kidney dysfunction, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or direct bilirubin higher than 1.5 times the upper limit of normal, or serum creatinine \>115 μmol/L;
- Pregnancy or lactation women, or people with cancer or mental illness;
- Factors affecting cortisol levels, including hypothalamus-pituitary-adrenal axis disease, autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis, etc.), diagnosed mental disease, Alzheimer's disease, alcoholism (alcohol \> 60 g/d for male, \>40 g/d for women) and corticosteroid therapy in the past 3 months (females with contraceptives or estrogen);
- Factors affecting saliva collection, such as serious oral problems (oral ulcers, gingival bleeding);
- Night shift workers, who are awake from 11:00 PM to 7:00 AM;
- Acute infection (body temperature ≥ 37.3 ℃ or C-reactive protein \> 50 mg/L).
- Cases:
- Aged 18 to 80 years old;
- Patients with suspected Cushing's syndrome or adrenal insufficiency.
- Corticosteroid therapy within the last 6 weeks;
- Acute infection;
- Severe oral conditions;
- Severe liver and kidney dysfunction;
- Alcoholism, depression, or other psychiatric disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Professor, Chief Physician, Deputy Director
Study Record Dates
First Submitted
August 27, 2025
First Posted
September 11, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 11, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share